Teva Pharmaceutical Reports Lower Third Quarter Sales and Earnings, Cuts FY22 Sales…
Teva Pharmaceutical Industries Ltd TEWA Third quarter revenue reached $3.59 billionshrinks 8% year-on-year, missing consensus of $3.83 billion. The decrease was primarily due to